Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Meta-Analysis Probes Cancer Risk Concern for JAK InhibitorsAlthough no increased cancer risk was seen vs methotrexate or placebo, Janus kinase inhibitors were associated with a higher
cancer risk than were tumor necrosis factor inhibitors in a meta-analysis.
Medscape Medical News, Apr 26, 2023
Normal CRP During RA Flares May Describe Unique PhenotypeIn about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year
period. The findings represent an "underappreciated, persistent phenotype."
